Central Nervous System Infections
18
3
5
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 18 trials
100.0%
+13.5% vs benchmark
6%
1 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (18)
National Study on Listeriosis and Listeria
Safety and Efficacy of Ventricular Irrigation for Ventriculitis
Analysis of Cerebrospinal Fluid in Patients With Cerebral Toxoplasmosis at CHSD (2004-2024)
Machine Learning to Predict Factors Affecting Rehabilitation Length of Stay and Healthcare Costs for Neurological Rehabilitation
Comparing Tigecycline Vs. Colistimethate in CNS Infections
Central Nervous System Disorders Following Hematopoietic Stem Cell Transplantation
A Study to Test Performance of Needle Placements for Neuraxial Procedures Using Tactile Imaging vs Control
Central Nervous System Infections in Denmark
INfectious DIsease REgistry BIObank
Device-related Central Nervous System Infections in Adult Intensive Care Units in Brazil
Effect of a Bundle of Interventions on the Outcomes of Patients With Intracranial Devices (ICP Monitor e EVD)
Economic Impact of mNGS on Diagnosis of Post-neurosurgical Central Nervous System Infection
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Venezuelan Equine Encephalitis Monovalent Virus-Like Particle Vaccine
Development of Risk Score Model and Decision Tree Algorithm for Predicting Infections With CRKp in Colonized Patients
Vietnam Cryptococcal Retention in Care Study Version 1.0
Singapore Neurologic Infections Program
Meropenem Penetration Across BBB in Patients With CNS Infection and Optimization of Meropenem Treatment